Table 3.
Patient activation measure survey outcomes (propensity weighted).
| Service | Usual care (preinterventiona) | Safety dashboard + bedside safety display only (postinterventionb) | Safety dashboard + bedside safety display + patient portal (postintervention) | P value | |||
| PAMc-13, n (CG-PAMd) | Mean (95% CI) | PAM-13, n (CG-PAM) | Mean (95% CI) | PAM-13, n (CG-PAM) | Mean (95% CI) | ||
| Neurology | 124 (34) | 61.3 (58.7-63.9) | 127 (8) | 64.8 (61.8-67.8) | 251 (55) | 71.4 (69.2-73.6) | <.001 |
| Oncology | 122 (14) | 60.6 (57.6-63.0) | 33 (4) | 55.4 (45.9-64.9) | 71 (6) | 64.7 (60.3-69.2) | .14 |
| Medicine | 250 (21) | 61.8 (59.9-63.8) | 340 (8) | 66.1 (64.3-67.9) | 206 (6) | 65.5 (63.0-68.1) | .01 |
aSurveyed September to November 2016.
bSurveyed December 2016 to May 2018.
cPAM: patient activation measure.
dCG-PAM: caregiver patient activation measure.